# China approves first oral GLP-1 weight-loss pill

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-china-oral-glp-weight-loss.html) · 2026-11-13 · Medicine
Page: https://themorning.science/story/china-approves-first-oral-glp-1-weight-loss-pill-b23e14ac22bc4ccc
Kind: launch · Impact: medium

## In brief

- China has approved its first orally administered GLP-1 weight-loss drug.
- The approval permits Eli Lilly to sell its orforglipron pill in China.
- The source cites a projection that 630 million adults in China could be overweight or obese by 2050.

## Why it matters

It adds an oral option to GLP-1 weight-loss treatments in a large market, which matters for researchers tracking obesity drug access and uptake.

## Coverage

- [China approves first oral GLP-1 weight-loss pill](https://medicalxpress.com/news/2026-11-china-oral-glp-weight-loss.html) — Medical Xpress - latest medical and health news stories, 2026-11-13

Tags: obesity, glp-1, drug-approval, china, eli-lilly

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science